AR046985A1 - Procedimiento para producir particulas para composiciones farmaceuticas - Google Patents
Procedimiento para producir particulas para composiciones farmaceuticasInfo
- Publication number
- AR046985A1 AR046985A1 ARP040104850A ARP040104850A AR046985A1 AR 046985 A1 AR046985 A1 AR 046985A1 AR P040104850 A ARP040104850 A AR P040104850A AR P040104850 A ARP040104850 A AR P040104850A AR 046985 A1 AR046985 A1 AR 046985A1
- Authority
- AR
- Argentina
- Prior art keywords
- procedure
- pharmaceutical compositions
- produce particles
- water
- particles
- Prior art date
Links
- 239000002245 particle Substances 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 3
- 229920002678 cellulose Polymers 0.000 abstract 1
- 239000001913 cellulose Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000000518 rheometry Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Transplantation (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Nutrition Science (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0329851A GB0329851D0 (en) | 2003-12-23 | 2003-12-23 | Process for producing particles for pharmaceutical compositions |
| GB0329854A GB0329854D0 (en) | 2003-12-23 | 2003-12-23 | Process for producing particles for pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR046985A1 true AR046985A1 (es) | 2006-01-04 |
Family
ID=34712711
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP040104850A AR046985A1 (es) | 2003-12-23 | 2004-12-22 | Procedimiento para producir particulas para composiciones farmaceuticas |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US20070161711A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1696888B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2007515464A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20060129303A (cg-RX-API-DMAC7.html) |
| AR (1) | AR046985A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2004305293A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0417985A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2551183C (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA06006887A (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ547806A (cg-RX-API-DMAC7.html) |
| RU (1) | RU2382634C2 (cg-RX-API-DMAC7.html) |
| TW (1) | TW200528140A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005060938A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140141075A1 (en) | 2012-11-21 | 2014-05-22 | Warner Chilcott Company, Llc | 5-aminosalicylic acid capsule formulation |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2916984B2 (ja) * | 1993-12-27 | 1999-07-05 | エスエス製薬株式会社 | 粒状製剤の製造法 |
| GB2292079B (en) * | 1994-08-12 | 1998-07-15 | Flexpharm Ltd | Coated prednisolone preparation for the treatment of inflamatory bowel disease |
| JPH09208458A (ja) * | 1996-02-02 | 1997-08-12 | Ss Pharmaceut Co Ltd | 不快な味がマスキングされた製剤 |
| DE19637082A1 (de) * | 1996-09-12 | 1998-03-19 | Boehringer Mannheim Gmbh | Schnellzerfallende Pellets |
| CA2269806C (en) * | 1996-10-28 | 2006-01-24 | Bernhard H. Van Lengerich | Embedding and encapsulation of controlled release particles |
| IT1298574B1 (it) * | 1998-02-06 | 2000-01-12 | Vectorpharma Int | Composizioni farmaceutiche in forma di microparticelle a base polimerica ottenute mediante estrusione e sferonizzazione |
| US6472421B1 (en) * | 1998-11-13 | 2002-10-29 | Nymox Corporation | Methods for treating, preventing, and reducing the risk of the onset of alzheimer's disease using an HMG CoA reductase inhibitor |
| US20030180352A1 (en) * | 1999-11-23 | 2003-09-25 | Patel Mahesh V. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| US6720000B2 (en) * | 2001-03-19 | 2004-04-13 | Three Rivers Pharmaceutical, Llc | Process for producing wet ribavirin pellets |
| BR0215175A (pt) * | 2001-12-21 | 2004-12-28 | Pfizer Prod Inc | Métodos para a granulação úmida de azitromicina |
| WO2004004696A1 (en) | 2002-07-05 | 2004-01-15 | Temrel Inc. | Controlled release composition |
| WO2004082615A2 (en) * | 2003-03-14 | 2004-09-30 | Nirmal Mulye | A process for preparing sustained release tablets |
-
2004
- 2004-12-15 EP EP04806077.6A patent/EP1696888B1/en not_active Expired - Lifetime
- 2004-12-15 US US10/581,595 patent/US20070161711A1/en not_active Abandoned
- 2004-12-15 JP JP2006546298A patent/JP2007515464A/ja active Pending
- 2004-12-15 NZ NZ547806A patent/NZ547806A/en unknown
- 2004-12-15 KR KR1020067014941A patent/KR20060129303A/ko not_active Ceased
- 2004-12-15 WO PCT/GB2004/005263 patent/WO2005060938A1/en not_active Ceased
- 2004-12-15 MX MXPA06006887A patent/MXPA06006887A/es active IP Right Grant
- 2004-12-15 RU RU2006126642/15A patent/RU2382634C2/ru not_active IP Right Cessation
- 2004-12-15 CA CA2551183A patent/CA2551183C/en not_active Expired - Fee Related
- 2004-12-15 AU AU2004305293A patent/AU2004305293A1/en not_active Abandoned
- 2004-12-15 BR BRPI0417985-4A patent/BRPI0417985A/pt not_active IP Right Cessation
- 2004-12-20 TW TW093139648A patent/TW200528140A/zh unknown
- 2004-12-22 AR ARP040104850A patent/AR046985A1/es unknown
-
2011
- 2011-05-09 US US13/103,580 patent/US20110210460A1/en not_active Abandoned
-
2012
- 2012-01-27 JP JP2012014751A patent/JP2012087147A/ja active Pending
-
2013
- 2013-04-11 US US13/861,117 patent/US20130249131A1/en not_active Abandoned
-
2014
- 2014-05-05 US US14/269,257 patent/US20140239526A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR20060129303A (ko) | 2006-12-15 |
| TW200528140A (en) | 2005-09-01 |
| JP2012087147A (ja) | 2012-05-10 |
| CA2551183C (en) | 2013-05-28 |
| US20070161711A1 (en) | 2007-07-12 |
| EP1696888A1 (en) | 2006-09-06 |
| RU2006126642A (ru) | 2008-01-27 |
| MXPA06006887A (es) | 2006-09-04 |
| EP1696888B1 (en) | 2015-04-08 |
| BRPI0417985A (pt) | 2007-04-17 |
| NZ547806A (en) | 2009-11-27 |
| CA2551183A1 (en) | 2005-07-07 |
| JP2007515464A (ja) | 2007-06-14 |
| US20130249131A1 (en) | 2013-09-26 |
| RU2382634C2 (ru) | 2010-02-27 |
| WO2005060938A1 (en) | 2005-07-07 |
| US20110210460A1 (en) | 2011-09-01 |
| AU2004305293A1 (en) | 2005-07-07 |
| US20140239526A1 (en) | 2014-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2019000209A1 (es) | Formulación novedosa administrable por la vía oral. | |
| BR132022001907E2 (pt) | Partículas de nanoalume contendo um agente de dimensionamento | |
| ES2155793B1 (es) | Particulas, especialmente microparticulas o nanoparticulas de oligosacaridos y monosacaridos reticulados, procedimientos para su preparacion y composiciones alimentarias, cosmeticas o farmaceuticas en las cuales estan presentes. | |
| ATE487470T1 (de) | Gel-stabilisierte wirkstoff-zusammensetzungen in nanoteilchengrösse | |
| AR040110A1 (es) | Formulaciones de fibrato en nanoparticulas | |
| NO20052635L (no) | Kontrollert frigivelsesdepot formuleringer | |
| BRPI0511441A (pt) | composições contendo uma partìcula de glucano oca ou partìcula de parede celular encapsulando um componente de terpeno, métodos de fabricação e uso das mesmas | |
| PE20030638A1 (es) | Formulacion granular de montelukast sodico | |
| CO5700698A2 (es) | Composiciones y metodos para el cuidado oral y personal | |
| ES2108272T3 (es) | Procedimiento de fabricacion de nanocapsulas con pared a base de proteinas reticuladas; nanocapsulas asi obtenidas y composiciones cosmeticas farmaceuticas y alimentarias que comprenden la aplicacion. | |
| DK1429731T3 (da) | Nanopartikelformuleringer indeholdende insulin | |
| CL2018003178A1 (es) | Composición farmacéutica | |
| ME03019B (me) | Farmaceutska kompozicija n-[2,4-bis(1,1- dimeтileтil)-5-hidroksifenil]- 1,4-dihidro-4-oksohinolin-3-karboksamida i njeno ordiniranje | |
| ES2130217T3 (es) | Uso de tiloxapol como dispersante y estabilizante de nanoparticulas. | |
| ES2182351T3 (es) | Composicion farmaceutica en aerosol. | |
| AR061929A1 (es) | Acidos nucleicos de union al factor derivado de celulas estomales sdf-1 | |
| PE20050488A1 (es) | Formas de administracion masticables, no comprimidas, dosificadas individualmente | |
| BR112022005755A2 (pt) | Formulações de cápsula de gel macio não animal, métodos de preparação, e métodos de uso das mesmas | |
| AR053977A1 (es) | Composiciones farmaceuticas con enmascaramiento de sabor | |
| EE05200B1 (et) | Asitromtsiin monohdraadina, selle valmistamismeetod ja selle kasutamine ravimkoostises | |
| PE20071003A1 (es) | Formulacion de suspension de fexofenadina | |
| AR046113A1 (es) | Composiciones antibioticas | |
| AR046985A1 (es) | Procedimiento para producir particulas para composiciones farmaceuticas | |
| ATE444739T1 (de) | Polymerzusammensetzung sowie diese enthaltende darreichungsformen | |
| BR0311965A (pt) | Formulações estabilizadas de antagonistas de receptores alfa adrenérgicos e os seus usos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |